| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a8d8f23368daae2470aa8000426153a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-2116 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate |
2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e30ffc6dd9aae6814bdc675d156bcfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6339893b20dd5d5d431865efec3fd9ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b58fcc0e67a83d04379281ef0ec6581 |
| publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022218655-A1 |
| titleOfInvention |
Composition using 4',6,7-trimethoxyisoflavone and catechol for managing pulmonary fibrosis |
| abstract |
Proposed is a composition for managing pulmonary fibrosis. The composition uses 4′,6,7-trimethoxyisoflavone and catechol that does not cytotoxicity and inhibits a TGF-β1 signal transfer pathway, thereby exhibiting EMT inhibitory activity. |
| priorityDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |